Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

<< Previous
Bullboard Posts
Next >>
Post by august202013on Nov 16, 2021 1:11pm
269 Views
Post# 34132612

BE FAIR MIR CANNOT BE COMPARED TO FACEBOOK DECISION MAKING

BE FAIR MIR CANNOT BE COMPARED TO FACEBOOK DECISION MAKINGIN ALL HONESTY MIR IS A GOOD COMPANY WITH LOTS OF PROSPECTS WITH DR HERMAS CHAN AND A REASONABLY WELL RUN WHICH LANDED ITSELF INTO 2 GOLDEN OPPORTUNITIES DURING SARS WHICH SAW SHARES PRICE WENT TO $3 + AND NOW WHICH SHARES HAS SHOT TO $0.89 SO FAR ?

DR CHAN DELIVERED ON BOTH OCCASSIONS BUT UNFORTUNATELY EVEN DURING THEIR SUBMISSION OF THEIR FIRST COVID19 TEST KIT

DR CHAN HAS ALREADY SUBMITTED FOR THE COVID19 TEST KIT PLUS TO INCORPORATE FOR SARS BUT IF CHECK THROUGH ARCHIVES WILL FIND OUT MIR WAS TOLD BY USA FDA TO
EXCLUDE TESTING FOR SARS AND WAS THEN GIVEN THE FIRST COVID19 TEST KIT USA FDA EUA WHICH EXCLUDED TEST FOR SARS.

LATER WHEN WHO SAYS THAT COVID19 ORIGINATE FROM SARS VIRUS USA FDA SUBSECUENTLY ACKNOWLEDGE IT AND THAT PROMPTED MIR TO RESUBMIT THEIR FIRST
COVID19 TEST KIT TO INCLUDE TEST FOR SARS VIRUS ALSO KNOWN AS COVID19 TEST KIT PLUS WHICH TURN OUT TO BE THEIR ORIGINAL FIRST SUBMISSION FOR USA FDA EUA  RESUBMITTED BUT IRONY STILL SUBJECTED TO WAIT TILL NOW !

ISSUE IS DR CHAN THE CEO AND MARCUS CFO SHOULD BY NOW REALISE WHAT THEY ARE UP TO AND LOGICALLY SHOULD PERSUE ALTERNATIVE MARKETING STRATEGY. SHAREHOLDERS ARE NOT AWARE OF THE ACTUAL POLITICAL SITUATION IN THE USA DOMINATION &/OR MONOPOLY OF THE COVID19 GAME ! 

HOWEVER, MIR CAN STILL MARKET OUTSIDE USA AND STILL MAKE SOME COINS IF THE DYNAMIC DUO MARKETED IT BACK IN JANUARY, 2021. FAST FORWARD 11 MONTHS
LATER THE DYNAMIC DUO STILL PREFER TO WAIT NOW REALLY NOT SURE WHAT HAS
USA FDA HAVE ON MIR ! EVEN BACK IN MARCH SOME SHAREHOLDERS WHICH HAVE SOME POLITICAL CLOUT IN ASIA HAVE VOLUNTEERED TO UNDERTAKE THE TASK TO ASSIST OF COURSE FOR SOME SMALL FEES. BUT STILL FELL TO DEFT EARS EVEN TILL TO TODAY. 

STILL HABOURING HOPE THAT SOMETHING GOOD SHOULD HAPPEN THAT IS WHY STILL COLLECTING IN VERY SMALL QUANTITIES. HOPEFULLY TO BE ABLE.HAVE SOME NEW YEAR CELEBRATION. GOOD LUCK AND HAPPY WAITING.
<< Previous
Bullboard Posts
Next >>